Business Wire

Biotech and Pharma Labs Performing Endpoint PCR Can Reduce Amplification Time to 15 Minutes With New Promega Reagent and Eppendorf Instrument Combination

HAMBURG, Germany & MADISON, Wis.--(BUSINESS WIRE)--Biotech and pharma labs performing endpoint polymerase chain reaction (PCR) can amplify samples in as little as 15 minutes with new Promega GoTaq® ...
The Scientist

PCR: Amplified to the End Point

30 years ago, polymerase chain reaction (PCR) burst onto the scene and steadily became one of the most common procedures in the lab. Advanced technologies have made it possible to achieve more ...
Nature

Beware trial end point comparisons

Neoadjuvant systemic therapy is the standard-of-care for patients with locally advanced breast cancer, but is increasingly used in those with early stage disease. Nobody can deny that neoadjuvant ...
Medscape

Presurgical Nivo/Chemo Boosts pCR Rates in NSCLC

Patients with resectable non–small cell lung cancer (NSCLC) often receive treatment before they undergo surgery. For such patients who achieve a pathologic complete response (pCR), the chances of ...